Crossmark

VEGF‐B signaling impairs endothelial glucose transcytosis by decreasing membrane cholesterol content

Crossref DOI link: https://doi.org/10.15252/embr.201949343

Published Online: 2020-05-24

Published Print: 2020-07-03

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Moessinger, Christine

Nilsson, Ingrid

Muhl, Lars

Zeitelhofer, Manuel

Heller Sahlgren, Benjamin

Skogsberg, Josefin

Eriksson, Ulf https://orcid.org/0000-0002-4439-3980
Funding

Funding for this research was provided by:

Vetenskapsrådet (2016‐02593)

Vetenskapsrådet (2017‐01794)

Hjärt-Lungfonden (20120077)

Hjärt-Lungfonden (20150547)

Cancerfonden (CAN 2016/633)

Novo Nordisk Fonden (NNF16OC0021172)

Novo Nordisk Fonden (NNF17OC0026942)

Karolinska Institutet

Svenska Sällskapet för Medicinsk Forskning
License Information

Version of Record valid from 2020-05-24
More Information

Publication History

Received: 2019-09-24

Accepted: 2020-04-21

Published: 2020-05-24